Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Thailand Health minister seeks input over cannabis regulation ...
  • France Government notifies TRIS of a bill classifying several narcotics ...
  • Czech Republic Proposal regulating HHC and other substances passes lower chamber ...
  • Canada Updated requirements for cannabis-containing topical products ...
  • United States Summary of proposals for next Farm Bill includes hemp definition ...
  • United States ‘Embarrassing’ lack of progress on medical cannabis bill ...
  • Ukraine Public consultation open on medical cannabis licensing requirements ...
  • Georgia US - United States Signed bill amends state hemp law in significant ways ...
  • Connecticut - United States House bill to amend state cannabis law passes to Senate ...
  • United States DEA and HHS agree on rescheduling of cannabis, now await OMB and public comment ...
  • United Kingdom FSA committee grants first-ever novel food authorisations for two CBD products ...
  • Germany Amendment to Cannabis Act to be discussed and referred to Health Committee ...
View all
Regulatory reports in Australasia

Australia: CBD and cannabis regulation, January 2023

Written by Laura Garay Gómez | 4th January 2023

This report provides a detailed overview of Australia's federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes...

New Zealand: CBD and cannabis regulation, May 2022

Written by Fernanda Tucunduva | 5th May 2022

This report offers a comprehensive overview of the current regulatory framework in New Zealand for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes ...

Medical and recreational cannabis – a global overview

Written by CannIntelligence | 4th March 2022

CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries ...

Regulatory report: Australia, October 2020

Written by CannIntelligence | 15th October 2020

CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD...

Regulation of CBD in edibles: an international overview

Written by CannIntelligence | 25th November 2019

The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one of the most popular product...

International regulation of CBD in cosmetics: a global overview

Written by CannIntelligence | 21st November 2019

The regulatory landscape for CBD products varies across the world and constantly changing, making compliance a potential minefield. This report provides an overview of the current legal status of CBD cosmetics in key markets around...

New Zealand regulatory snapshot

Written by Marija Obradovic | 14th January 2019

CBD-Intel guides you through the small print of CBD regulation in New Zealand, where CBD is classed as medicinal and the only part of the hemp plant that can be used in food is the...

A highly restrictive regime: Australia regulatory report

Written by Pablo Cano Trilla | 29th November 2018

Australia is a highly restrictive market for CBD, with limits on growing and extraction and an absolute prohibition on CBD in consumer products. This report details what is and what is not allowed ...

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy.